Yvonne Linney - Aug 15, 2022 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
Director
Signature
/s/ R. Erik Holmlin, Attorney-in-Fact
Stock symbol
BNGO
Transactions as of
Aug 15, 2022
Transactions value $
-$64,802
Form type
4
Date filed
8/17/2022, 05:55 PM
Previous filing
Jun 13, 2022
Next filing
Jun 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNGO Common Stock Options Exercise $7.6K +20K $0.38 20K Aug 15, 2022 Direct
transaction BNGO Common Stock Sale -$72.4K -20K -100% $3.62 0 Aug 15, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (Right to Buy) Options Exercise $0 -20K -24.71% $0.00 60.9K Aug 15, 2022 Common Stock 20K $0.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in equal monthly installments over a three year period such that the option is fully vested on May 4, 2023, subject to full vesting acceleration upon a change in control (as defined in Bionano Genomic's equity incentive plan).